Loading clinical trials...
Loading clinical trials...
Cannabis Use in Pregnancy and Downstream Effects on Maternal and Infant Health (CUPiD): A Pilot Prospective Cohort Study
Conditions
Interventions
Cannabis use in pregnancy or cannabis exposure in utero
Locations
4
Canada
Kingston Health Sciences Centre
Kingston, Ontario, Canada
Children's Hospital of Eastern Ontario
Ottawa, Ontario, Canada
The Ottawa Hospital - Civic Campus
Ottawa, Ontario, Canada
The Ottawa Hospital - General Campus
Ottawa, Ontario, Canada
Start Date
October 10, 2022
Primary Completion Date
January 7, 2025
Completion Date
February 1, 2025
Last Updated
April 16, 2025
NCT05855668
NCT06878859
NCT07011615
NCT07184983
NCT06077292
NCT06430580
Lead Sponsor
Ottawa Hospital Research Institute
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions